Lexpos News

/Lexpos News

Early advance payment timetable for 2024

Pharmacy owners should submit their January 2024 FP34C submission figures through the Manage Your Service (MYS) portal by the end of 5 February 2024 to receive earlier advance payments on Friday 9 February 2024. The 100% advance payments will continue to be based on the items declared on the FP34C and the latest available Average Item Value [...]

The post Early advance payment timetable for 2024 appeared first on Community Pharmacy England.

By |February 5th, 2024|Lexpos News|Comments Off on Early advance payment timetable for 2024

C-19 vacs: NHSE extends contracts until 31st August

NHS England has written to pharmacies currently providing the COVID-19 vaccination service to ask whether they would be willing to extend the duration of their current contract to provide the service until 31st August 2024. This extension is to provide cover for a potential Spring booster programme, should the Joint Committee on Vaccination and Immunisation [...]

The post C-19 vacs: NHSE extends contracts until 31st August appeared first on Community Pharmacy England.

By |February 2nd, 2024|C-19 vaccination, COVID-19, Lexpos News|Comments Off on C-19 vacs: NHSE extends contracts until 31st August

GPhC issues guidance on safe service provision

The General Pharmaceutical Council (GPhC) has released advice for pharmacy owners and superintendents on safely implementing pharmacy services following the start of the Pharmacy First Service across England. This advice comes amidst persistent pressures and demands on community pharmacy services, as well as the growing suite of services offered by pharmacy teams. The GPhC has [...]

The post GPhC issues guidance on safe service provision appeared first on Community Pharmacy England.

By |February 1st, 2024|Lexpos News|Comments Off on GPhC issues guidance on safe service provision

MHRA Class 4 Medicines Defect Information: Gepretix 100mg Capsules (Exeltis UK Limited)

Class 4 Medicines Defect Information: Gepretix 100mg Capsules (Exeltis UK Limited) Drug alert number: EL (24)A/04 Date issued: 01 February 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Gepretix 100mg Capsules (Exeltis UK Limited) Company name: Exeltis UK Limited Product name: Gepretix 100mg Capsules, [...]

The post MHRA Class 4 Medicines Defect Information: Gepretix 100mg Capsules (Exeltis UK Limited) appeared first on Community Pharmacy England.

By |February 1st, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Gepretix 100mg Capsules (Exeltis UK Limited)

MHRA issues new materials for valproate safety measures

This week the MHRA has issued new safety and educational materials for patients and healthcare professionals to support the implementation of the new regulatory measures. These materials include: Updated Patient Guide Updated Healthcare Professional Guide Updated Annual Risk Acknowledgement Form New Risk Acknowledgment Form for male patients starting valproate Patient Card Pharmacy Poster Warning Stickers [...]

The post MHRA issues new materials for valproate safety measures appeared first on Community Pharmacy England.

By |February 1st, 2024|Lexpos News|Comments Off on MHRA issues new materials for valproate safety measures